rs12316424

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001378609.3(OTOGL):​c.3480T>C​(p.Cys1160Cys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.013 in 1,612,322 control chromosomes in the GnomAD database, including 2,357 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.069 ( 1231 hom., cov: 32)
Exomes 𝑓: 0.0071 ( 1126 hom. )

Consequence

OTOGL
NM_001378609.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.441

Publications

1 publications found
Variant links:
Genes affected
OTOGL (HGNC:26901): (otogelin like) The protein encoded by this gene belongs to the otogelin family. This gene is expressed in the inner ear of vertebrates with the highest level of expression seen at the embryonic stage and lowest in adult. Knockdown studies in zebrafish suggest that this gene is essential for normal inner ear function. Mutations in this gene are associated with autosomal recessive deafness. [provided by RefSeq, Dec 2012]
OTOGL Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 84B
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.66).
BP6
Variant 12-80313505-T-C is Benign according to our data. Variant chr12-80313505-T-C is described in ClinVar as Benign. ClinVar VariationId is 226943.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.441 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.236 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OTOGLNM_001378609.3 linkc.3480T>C p.Cys1160Cys synonymous_variant Exon 31 of 59 ENST00000547103.7 NP_001365538.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OTOGLENST00000547103.7 linkc.3480T>C p.Cys1160Cys synonymous_variant Exon 31 of 59 5 NM_001378609.3 ENSP00000447211.2 Q3ZCN5
OTOGLENST00000646859.1 linkc.3345T>C p.Cys1115Cys synonymous_variant Exon 35 of 63 ENSP00000496036.1 A0A2R8YF04

Frequencies

GnomAD3 genomes
AF:
0.0691
AC:
10514
AN:
152094
Hom.:
1230
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.240
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0272
Gnomad ASJ
AF:
0.000576
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000620
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00100
Gnomad OTH
AF:
0.0473
GnomAD2 exomes
AF:
0.0179
AC:
4405
AN:
246514
AF XY:
0.0133
show subpopulations
Gnomad AFR exome
AF:
0.247
Gnomad AMR exome
AF:
0.0123
Gnomad ASJ exome
AF:
0.000697
Gnomad EAS exome
AF:
0.0000556
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000725
Gnomad OTH exome
AF:
0.00962
GnomAD4 exome
AF:
0.00711
AC:
10378
AN:
1460110
Hom.:
1126
Cov.:
31
AF XY:
0.00608
AC XY:
4419
AN XY:
726436
show subpopulations
African (AFR)
AF:
0.248
AC:
8274
AN:
33344
American (AMR)
AF:
0.0132
AC:
592
AN:
44692
Ashkenazi Jewish (ASJ)
AF:
0.000766
AC:
20
AN:
26114
East Asian (EAS)
AF:
0.0000757
AC:
3
AN:
39620
South Asian (SAS)
AF:
0.000313
AC:
27
AN:
86210
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53374
Middle Eastern (MID)
AF:
0.00694
AC:
40
AN:
5764
European-Non Finnish (NFE)
AF:
0.000405
AC:
450
AN:
1110668
Other (OTH)
AF:
0.0161
AC:
972
AN:
60324
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
389
777
1166
1554
1943
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
244
488
732
976
1220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0693
AC:
10545
AN:
152212
Hom.:
1231
Cov.:
32
AF XY:
0.0664
AC XY:
4940
AN XY:
74442
show subpopulations
African (AFR)
AF:
0.240
AC:
9953
AN:
41474
American (AMR)
AF:
0.0271
AC:
415
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.000576
AC:
2
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.00100
AC:
68
AN:
68008
Other (OTH)
AF:
0.0482
AC:
102
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
401
802
1203
1604
2005
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
96
192
288
384
480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0281
Hom.:
256
Bravo
AF:
0.0791
Asia WGS
AF:
0.0200
AC:
70
AN:
3478
EpiCase
AF:
0.000654
EpiControl
AF:
0.00130

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 15, 2019
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:2
Nov 24, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Cys1151Cys in exon 30 of OTOGL: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue and is not located wi thin the splice consensus sequence. It has been identified in 22.3% (963/4318) o f African American chromosomes from a broad population by the NHLBI Exome Sequen cing Project (http://evs.gs.washington.edu/EVS; dbSNP rs12316424). -

Oct 23, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.66
CADD
Benign
8.6
DANN
Benign
0.73
PhyloP100
0.44
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12316424; hg19: chr12-80707285; API